Abbott Laboratories News

Abbott Laboratories | 8-K: Current report

May 1 16:07 ET

Abbott Laboratories | 8-K: Current report

Apr 29 16:13 ET

Abbott Laboratories | 8-K: Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges

Apr 17 07:39 ET

Abbott Laboratories | DEF 14A: Definitive information statements

Mar 15 22:27 ET

Abbott Laboratories | DEFA14A: Others

Mar 15 16:07 ET

Abbott Laboratories | 8-K: Current report

Jan 29 16:15 ET

Abbott Laboratories | 8-K: Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook

Jan 24 07:39 ET

Abbott Laboratories | 8-K: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range

Oct 18, 2023 07:37 ET

Abbott Laboratories | 8-K/A: Current report (Amendment)

Sep 1, 2023 16:13 ET

Abbott Laboratories | 8-K: Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business

Jul 20, 2023 08:29 ET

Abbott Laboratories | 8-K: Current report

Jun 12, 2023 10:32 ET

Abbott Laboratories | 8-K/A: Current report (Amendment)

Jun 9, 2023 16:05 ET

Abbott Laboratories | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

May 3, 2023 06:13 ET

Abbott Laboratories | 8-K: Current report

May 2, 2023 06:00 ET

Abbott Laboratories | 8-K: Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business

Apr 19, 2023 07:25 ET

Abbott Laboratories | DEFA14A: Others

Mar 17, 2023 16:23 ET

Abbott Laboratories | DEF 14A: Definitive proxy statements

Mar 17, 2023 16:22 ET

Abbott Laboratories | 8-K: Current report

Feb 17, 2023 16:23 ET

Abbott Laboratories | 8-K: Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook

Jan 25, 2023 07:38 ET

Abbott Laboratories | 8-K: Current report

Dec 9, 2022 16:02 ET